loader image
Saturday, February 24, 2024
75.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Mentally stimulating jobs linked to lower risk of dementia in old age

Translate to Spanish or other 102 languages!

People with mentally stimulating jobs have a lower risk of dementia in old age than those with non-stimulating jobs. Image for illustration purposes

Mega Doctor News

- Advertisement -

By BMJ

Newswise — People with mentally stimulating jobs have a lower risk of dementia in old age than those with non-stimulating jobs, finds a study published by The BMJ today. 

One possible explanation is that mental stimulation is linked to lower levels of certain proteins that may prevent brain cells forming new connections (processes called axonogenesis and synaptogenesis).

- Advertisement -

Cognitive stimulation is assumed to prevent or postpone the onset of dementia. But trial results have varied and most recent long-term studies have suggested that leisure time cognitive activity does not reduce risk of dementia.

Exposure to cognitive stimulation at work typically lasts considerably longer than cognitively stimulating hobbies, yet work-based studies have also failed to produce compelling evidence of benefits.

So an international team of researchers set out to examine the association between cognitively stimulating work and subsequent risk of dementia and to identify protein pathways for this association.

Their findings are based on studies from the United Kingdom, Europe, and the United States looking at links between work related factors and chronic diseases, disability, and mortality.

Three associations were examined: cognitive stimulation and dementia risk in 107,896 participants (42% men; average age 45 years) from seven studies from the IPD-Work consortium, a collaborative research project of 13 European cohort studies; cognitive stimulation and proteins in a random sample of 2,261 participants from one study; and proteins and dementia risk in 13,656 participants from two studies.

- Advertisement -

Cognitive stimulation at work was measured at the start of the study and participants were tracked for an average of 17 years to see if they developed dementia. 

Cognitively stimulating “active” jobs include demanding tasks and high job decision latitude (also known as job control), while non-stimulating “passive” jobs are those with low demands and lack of job control.

After adjusting for potentially influential factors, including age, sex, educational attainment, and lifestyle, risk of dementia was found to be lower for participants with high compared with low cognitive stimulation at work (incidence 4.8 per 10,000 person years in the high stimulation group and 7.3 in the low stimulation group).

This finding remained after further adjustments for a range of established dementia risk factors in childhood and adulthood, cardiometabolic diseases (diabetes, coronary heart disease and stroke), and the competing risk of death. 

The association did not differ between men and women or those younger and older than 60, but there was an indication that the association was stronger for Alzheimer’s disease than for other dementias. 

Cognitive stimulation was also associated with lower levels of three proteins linked to both cognitive stimulation in adulthood and dementia, providing possible clues to underlying biological mechanisms.

This was an observational study, so can’t establish cause, and the researchers cannot rule out the possibility that some of the observed dementia risk may be due to other unmeasured factors.

However, this was a large, well designed study that used different types of analyses to provide a certain degree of validation for the main findings, and the results seem to be generalizable across different populations. 

As such, the researchers say their findings suggest that people with cognitively stimulating jobs have a lower risk of dementia in old age than those with non-stimulating jobs.

“The findings that cognitive stimulation is associated with lower levels of plasma proteins that potentially inhibit axonogenesis and synaptogenesis and increase the risk of dementia might provide clues to underlying biological mechanisms,” they conclude. Despite considerable previous research, the role of work related mental enrichment in dementia has remained unclear, says Serhiy Dekhtyar at the Karolinska Institutet, in a linked editorial.

“This new work is an important reminder to all in the specialty of dementia prevention that we can only go so far with intervention studies that are short, late, small, and include only people who are heterogenous in their risk profiles to reveal any benefit of mental enrichment on dementia risk,” he writes.

“Carefully designed, large, population based studies with long periods of follow-up that also aim to provide biological clues, can be an important addition to randomized controlled trials. Kivimäki and colleagues’ study is an outstanding example,” he concludes.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

PSJA ISD Student Leaders Annual Track of Hope Cancer Awareness Walk, Feb. 24th 

With many members of the PSJA community affected by cancer, PSJA ISD high school students organized the Track of Hope Cancer Awareness & Relief Walk event to help raise awareness and funds to give back.

Epidemiology Expert Dr. Scott Lillibridge Takes Helm at DHR Health Institute for Research and Development

Dr. Lillibridge's distinguished federal career with the Centers for Disease Control and Prevention (CDC) includes serving as Special Assistant to the Secretary for the Department of Health and Human Services, Director for the CDC Bioterrorism Preparedness and Response Program, and Medical Director for the US Office of Foreign Disaster Assistance (USAID).

Aida Coronado Garcia’s Back to the Beginning, A Day of Leadership at Perkins Middle School     

Coronado Garcia's visit was more than just a ceremonial return; it was an interactive and insightful activity into the daily operations and challenges of running a middle school.

New Cell-Based Immunotherapy Offered for Melanoma

Washington University doctors and researchers were involved in clinical trials that led to the FDA approval.
- Advertisement -
×